Avena Merger Sub Inc. /
Forte Biosciences, Inc.
Avena Merger Sub Inc. makes offer for Forte Biosciences, Inc.




Source for the buyer and target: ARGENX SE
For the buyer and target.
“Agreement and Plan of Merger, dated as of July 26, 2026, by and among Forte Biosciences, Inc., argenx BV and Avena Merger Sub Inc. (incorporated by reference to Exhibit 2.1 to the Forte Biosciences, Inc. Current Report on Form 8-K filed with the SEC on July 27, 2026).”
Published 6 Aug 2026
Open the sourceWhat happened
Avena Merger Sub Inc. is offering to acquire Forte Biosciences, Inc. for $77.00 per Share, net to the seller in cash, without interest, subject to applicable withholding of taxes. [01]
Avena Merger Sub Inc. is a wholly owned subsidiary of argenx BV. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Avena Merger Sub Inc. makes offer for Forte Biosciences, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
Deal Web
Every firm and person on this deal, and how they connect. Open any name to see their other deals.
Agreement signed · Avena Merger Sub Inc. / Forte Biosciences, Inc. deal (Agreement signed, published 6 Aug 2026).
Published 6 Aug 2026- Published by ARGENX SE
Deal Web as a list
- Avena Merger Sub Inc. (Buyer) buyer this deal. Avena Merger Sub Inc.: 1 deal on Carrywatch.
- Forte Biosciences, Inc. (Target) target this deal. Forte Biosciences, Inc.: 1 deal on Carrywatch.
By email · Weekly